COLLABORATION AND LICENSE AgreementCollaboration and License Agreement • February 28th, 2019 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 28th, 2019 Company Industry JurisdictionThis Collaboration and License Agreement (the “Agreement”) is entered into as of October 29, 2018 (the “Effective Date”), by and between Rigel Pharmaceuticals, Inc., a Delaware company having an address at 1180 Veterans Blvd., South San Francisco, CA 94080, USA (“Rigel”) and Kissei Pharmaceutical Co. Ltd., a Japanese company having an address at 19-48 Yoshino, Matsumoto, Nagano 399-8710, Japan (“Kissei”). Rigel and Kissei may be referred to herein individually as a “Party” or collectively as the “Parties”.
SUPPLY AGREEMENTSupply Agreement • February 28th, 2019 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 28th, 2019 Company Industry JurisdictionThis Supply Agreement (the “Supply Agreement”) is entered into as of October 29, 2018 (the “Effective Date”) by and between Rigel Pharmaceuticals, Inc., a Delaware company having an address at 1180 Veterans Blvd., South San Francisco, CA 94080, USA (“Rigel”) and Kissei Pharmaceutical Co. Ltd., a Japanese company having an address at 19-48 Yoshino, Matsumoto, Nagano 399-8710, Japan (“Kissei”). Rigel and Kissei may be referred to herein individually as a “Party” or collectively as the “Parties”.